0
0
11/14/22 at 8:54pm
Organization
Ars Technica
Author
John Timmer
29 words
0
Comments
New trial has limited effect on cancer, but technology is likely to see further use.
You are the first to view
https://arstechnica.com/science/2022/11/gene-editing-used-in-new-clinical-trial-against-cancer/
Create an account
or login to join the discussion